Literature DB >> 15057463

Evaluation of PCR based on gene apxIVA associated with 16S rDNA sequencing for the identification of Actinobacillus pleuropneumoniae and related species.

Mateus Matiuzzi da Costa1, Catia Silene Klein, Raquel Balestrin, Augusto Schrank, Itamar Antonio Piffer, Sérgio Ceroni da Silva, Irene Silveira Schrank.   

Abstract

The pleuropneumonia caused by Actinobacillus pleuropneumoniae (App) is one the most important swine respiratory diseases. Biochemical and serological tests are widely applied for App diagnosis and characterization. However, in some isolates, conflicting results are found. The present work focus on the characterization of 29 isolates biochemically classified as A. pleuropneumoniae, collected from swine in herds with or without a clinical history of pleuropneumonia. Sixteen isolates were from healthy swine, initially classified as nonserotypable A. pleuropneumoniae; they displayed differences in the molecular characterization patterns of App (genes cpx and apxI, II, and III). Those bacteria that could not be serotyped were submitted to rDNA 16S sequencing. All 29 isolates were analyzed by PCR for the presence of the apxIVA gene. Thirteen isolates (45%) were confirmed to be A. pleuropneumoniae by PCR, nine being from diseased animals (31%) and four from healthy animals (14%) with conclusive serotyping. The rDNA 16S sequencing was used to classify the other 16 isolates in related species other than A. pleuropneumoniae, resulting in eleven A. minor, three A. porcinus, and two Pasteurella sp. Because of conflicting results between biochemical tests and rDNA 16S sequencing, the biochemical characterization was repeated, and the new results were in agreement with the rDNA 16S sequencing data. Biochemical characterization proved to be efficient for the majority of the A. pleuropneumoniae isolates. Nevertheless, conventional tests can render conflicting results, and other methodologies, such as amplification of A. pleuropneumoniae specific apxIVA gene and rDNA 16S sequencing, are very useful for improved classification. We also observed a great variety in rDNA 16S sequences from different A. minor isolates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057463     DOI: 10.1007/s00284-003-4162-x

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  5 in total

1.  Predicting genetic traits and epitope analysis of apxIVA in Actinobacillus pleuropneumoniae.

Authors:  Min-Kyoung Shin; Seung-Bin Cha; Won-Jung Lee; Han Sang Yoo
Journal:  J Microbiol       Date:  2011-06-30       Impact factor: 3.422

2.  "Pathotyping" Multiplex PCR Assay for Haemophilus parasuis: a Tool for Prediction of Virulence.

Authors:  Kate J Howell; Lucy A Weinert; Sarah E Peters; Jinhong Wang; Juan Hernandez-Garcia; Roy R Chaudhuri; Shi-Lu Luan; Øystein Angen; Virginia Aragon; Susanna M Williamson; Paul R Langford; Andrew N Rycroft; Brendan W Wren; Duncan J Maskell; Alexander W Tucker
Journal:  J Clin Microbiol       Date:  2017-06-14       Impact factor: 5.948

3.  Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.

Authors:  Fei Zhang; Qin Zhao; Keji Quan; Zhuang Zhu; Yusheng Yang; Xintian Wen; Yung-Fu Chang; Xiaobo Huang; Rui Wu; Yiping Wen; Qigui Yan; Yong Huang; Xiaoping Ma; Xinfeng Han; Sanjie Cao
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

4.  A CRISPR/Cas12a-assisted rapid detection platform by biosensing the apxIVA of Actinobacillus pleuropneumoniae.

Authors:  Tian Luan; Lu Wang; Jiyu Zhao; Hui Luan; Yueling Zhang; Chunlai Wang; Paul R Langford; Siguo Liu; Wanjiang Zhang; Gang Li
Journal:  Front Microbiol       Date:  2022-09-09       Impact factor: 6.064

5.  In silico capsule locus typing for serovar prediction of Actinobacillus pleuropneumoniae.

Authors:  Siou-Cen Li; Jing-Fang Huang; Yu-Ting Hung; Hsiu-Hui Wu; Jyh-Perng Wang; Jiunn-Horng Lin; Zeng-Weng Chen; Shih-Ling Hsuan
Journal:  Microb Genom       Date:  2022-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.